drugset / Trial / NCT00170677
Topotecan Weekly Versus Topotecan Day 1-5 in Patient With Platin-resistant Ovarian Cancer
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Comparison of topotecan weekly vs. topotecan day 1-5. The compatibility and activity are to be examined.
Timeline
- Start
- 2005-09
- Primary completion
- 2013-01
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Topotecan | Small molecule | 1.25 mg/m2 | Intravenous |
| Comparator | Topotecan | Small molecule | 4 mg/m2 | Intravenous |